Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.23.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenue:    
Total revenue $ 5,433 $ 5,031
Cost of revenue 2,231 1,800
Gross profit 3,202 3,231
Research and development costs 3,023 2,901
Sales and marketing expenses 2,933 2,018
General and administrative expenses 2,958 2,176
Operating loss (5,712) (3,864)
Other expense:    
Other (expense) income, net (11) 11
Interest income (expense), net 114 (106)
Net loss $ (5,609) $ (3,959)
Net loss per share attributable to common stockholders:    
Basic (in dollars per share) $ (0.23) $ (0.17)
Diluted (in dollars per share) $ (0.23) $ (0.17)
Weighted average shares used in computing net loss per share:    
Basic (in shares) 24,583,163 23,682,442
Diluted (in shares) 24,583,163 23,682,442
Product revenue    
Revenue:    
Total revenue $ 2,630 $ 3,163
Service and other revenue    
Revenue:    
Total revenue $ 2,803 $ 1,868